Physician–pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients

DiPaula, Bethany A.; Menachery, Elizabeth

doi:10.1331/japha.2015.14177

Cited by 65 publications

(67 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…“Physician–Pharmacist Collaborative Care Model for Buprenorphine‐Maintained Opioid‐Dependent Patients” …”

Section: Resultsmentioning

confidence: 99%

“…While pharmacist involvement in drug courts is still new, their utilization has proved invaluable for the patient in both legal proceedings and long‐term recovery. Finally, a study by DiPaula and Menachery demonstrated that pharmacists can play a vital part in the management of patients receiving MOUD . The authors demonstrated how giving pharmacists more responsibility over the primary pharmacological management of patients could improve patient outcomes while also providing potential cost savings.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacists and the opioid crisis: A narrative review of pharmacists' practice roles

Bratberg

Smothers

Collins

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Introduction Nearly 2.5 million Americans have an opioid use disorder (OUD) related to prescription and/or illicit opioids. Pharmacists, as one of the most accessible care providers, are essential in mitigating the mortality and morbidity of the opioid overdose crisis. Pharmacists are involved in numerous care activities related to this crisis and to caring for patients with an OUD. Objective The objective of this paper was to conduct a literature review to highlight several pharmacist‐driven practices that provide a broad range of prevention, harm reduction, treatment, and recovery services to patients affected or potentially affected by the opioid crisis. Methods Articles had to meet the criteria of describing pharmacist‐led practice related to providing care to patients at risk of an opioid overdose, with an OUD, or related to opioid safety. The literature search was conducted in 2018 and utilized numerous sources including: OneSearch (EBSCOhost), PubMed, ScienceDirect, and the Journal of the American Pharmacists Association Opioid Topic Collection. Results Seven articles were chosen for inclusion in this review. These studies report on innovative programs and practices that describe the role of pharmacists in the opioid crisis. Studies demonstrate the types of involvement pharmacists have in caring for patients throughout the care continuum: actively engaged in upstream interventions aimed at preventing misuse and improve safety; screening and monitoring opioid prescribing and usage; providing access to naloxone; and, assisting in the recovery and rehabilitation process of patients with OUD, including collaboratively managing OUD with evidence‐based pharmacotherapy. Conclusion The studies included in our narrative review demonstrate how innovative programs and practices can expand the role of pharmacists throughout the entire spectrum of interventions applied to the opioid crisis by capitalizing on their existing skill sets and knowledge.

show abstract

“…“Physician–Pharmacist Collaborative Care Model for Buprenorphine‐Maintained Opioid‐Dependent Patients” …”

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Pharmacists and the opioid crisis: A narrative review of pharmacists' practice roles

Bratberg

Smothers

Collins

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…The current literature on pharmacist engagement in chronic pain management is limited to specialty care settings (eg, palliative care), investigations of patient-centered medical home designation, or descriptive reports. 15,16,[22][23][24][25] To our knowledge, this is the first published study of the impact of a pharmacist-led intervention focused on comprehensive chronic pain management in a family medicine setting. The purpose of this study was to evaluate the impact of a previsit pharmacist review of highrisk patients treated with opioids for chronic noncancer pain for compliance with CDC recommendations at a family medicine residency clinic.…”

mentioning

confidence: 99%

“…[15][16][17][18][19][20][21] Because of the need for monitoring and clinician follow-up, the unique pharmacologic properties, and the potential for diversion, opioid therapy in chronic pain presents an opportunity for pharmacist involvement. The current literature on pharmacist engagement in chronic pain management is limited to specialty care settings (eg, palliative care), investigations of patient-centered medical home designation, or descriptive reports.…”

mentioning

confidence: 99%

Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety

et al. 2018

View full text Add to dashboard Cite

Introduction: Primary care providers (PCPs) account for half of opioid prescriptions, often feel chronic pain patients are challenging to manage, and there is wide variability in practice patterns. The purpose of this pilot study was to evaluate the impact of a previsit pharmacist review of high-risk patients treated with opioids for chronic pain on compliance to guideline recommendations at a family medicine residency clinic.Methods: All adult patients with an appointment for chronic pain who were prescribed >50 morphine milligram equivalents (MMEs)/day had charts reviewed by a pharmacist before each appointment; recommendations were sent electronically to the provider before the appointment. After 4 months of implementation, each patient's chart was manually reviewed to gather outcome variables. The primary outcomes were the mean MMEs/day and pain scores.Results: Pharmacist previsit recommendations were provided for 45 patients. When comparing outcomes before and after intervention, the mean MMEs/day decreased by 14% (P < .001), with no change in pain scores (P ‫؍‬ .783). Statistically significant improvements were noted in multiple other secondary opioid safety outcomes.

show abstract

“…1 Pharmacists are one of the most accessible health care professionals, and models of pharmacy-led SUD care teams have been described. [8][9][10][11] However, pharmacists must be adequately prepared to provide compassionate, evidence-based care to patients with SUD.…”

mentioning

confidence: 99%

Impact of elective on students’ perceptions of treating patients with a substance use disorder

Jarvi¹,

Hughes²,

Shepherd³

et al. 2020

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

Physician–pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients

Cited by 65 publications

References 30 publications

Pharmacists and the opioid crisis: A narrative review of pharmacists' practice roles

Pharmacists and the opioid crisis: A narrative review of pharmacists' practice roles

Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety

Impact of elective on students’ perceptions of treating patients with a substance use disorder

Contact Info

Product

Resources

About